Global Hemp Group Inc. cancelled the transaction announced on January 15, 2024

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company’s has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.